Juliane Glória

Dr. Juliane Glória

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2022 in Experimental Biology and Medicine
Verified
Journal Article
Closed access
AFAdélia Marques de Figueiredo
Adélia Marques de Figueiredo
JGJuliane Glória
Juliane Glória
YCYury Oliveira Chaves
Yury Oliveira Chaves
WNWalter Luiz Lima Neves
Walter Luiz Lima Neves
LMLuis André Mariuba
Luis André Mariuba
Microsphere-based flow cytometry is a highly sensitive emerging technology for specific detection and clinical analysis of antigens, antibodies, and nucleic acids of interest. In this review, studies that focused on the application of flow cytometry as a viable alternative for the investigation of infectious diseases were analyzed. Many of the studies involve research aimed at epidemiological surveillance, vaccine candidates and early diagnosis, non-infectious diseases, specifically cancer, and emphasize the simultaneous detection of biomarkers for early diagnosis, with accurate results in a non-invasive approach. The possibility of carrying out multiplexed assays affords this technique high versatility and performance, which is evidenced in a series of clinical studies that have verified the ability to detect several molecules in low concentrations and with minimal sample volume. As such, we demonstrate that microsphere-based flow cytometry presents itself as a promising technique that can be adopted as a fundamental element in the development of new diagnostic methods for a number of diseases.

15 September 2020 in High Performance Polymers
Verified
Journal Article
Closed access
PDF file
JGJuliane Glória
Juliane Glória
WBWalter Brito
Walter Brito
AGAriamna Gandarilla
Ariamna Gandarilla
DLDuniesky Larrude
Duniesky Larrude
JCJacqueline Carlos
Jacqueline Carlos
LMLuis André Mariuba
Luis André Mariuba
Since their discovery, carbon nanotubes were used for numerous applications in the most diverse knowledge areas. However, the lack of solubility of these molecules in aqueous media compromises their beneficial properties for certain applications. Several methods to solubilize carbon nanotubes are described, however, depending on the intended application, the impact that the solubilization has on the physical and chemical properties needs to be considered. In the present study, a simple methodology is described that utilizes polyvinylpyrrolidone combined with sonication and centrifugation to solubilize multiwalled carbon nanotubes. Proteins were coupled to the surface of the solubilized products and characterized using various spectroscopic and electron microscopic techniques, evaluating the characteristics and integrity of the nanoparticle after the process. It was successfully demonstrated that nanotubes can be solubilized through a simple technique, without compromising their chemical characteristics, which makes them suitable materials for use in biomedical applications, due to their biocompatibility and lack of toxicity, among others.

9 November 2021 in Experimental Biology and Medicine
Verified
Journal Article
Open access
PDF file
FZFernando Berton Zanchi
Fernando Berton Zanchi
LMLuis André Mariuba
Luis André Mariuba
VNValdinete Nascimento
Valdinete Nascimento
VSVictor Souza
Victor Souza
ACAndré Corado
André Corado
Felipe NavecaFelipe Naveca
Felipe Naveca
The coronavirus disease COVID-19 has been the cause of millions of deaths worldwide. Among the SARS-CoV-2 proteins, the non-structural protein 1 (NSP1) has great importance during the virus infection process and is present in both alpha and beta-CoVs. Therefore, monitoring of NSP1 polymorphisms is crucial in order to understand their role during infection and virus-induced pathogenicity. Herein, we analyzed how mutations detected in the circulating SARS-CoV-2 in the population of the city of Manaus, Amazonas state, Brazil could modify the tertiary structure of the NSP1 protein. Three mutations were detected in the SARS-CoV-2 NSP1 gene: deletion of the amino acids KSF from positions 141 to 143 (delKSF), SARS-CoV-2, lineage B.1.195; and two substitutions, R29H and R43C, SARS-CoV-2 lineage B.1.1.28 and B.1.1.33, respectively. The delKSF was found in 47 samples, whereas R29H and R43C were found in two samples, one for each mutation. The NSP1 structures carrying the mutations R43C and R29H on the N-terminal portion (e.g. residues 10 to 127) showed minor backbone divergence compared to the Wuhan model. However, the NSP1 C-terminal region (residues 145 to 180) was severely affected in the delKSF and R29H mutants. The intermediate variable region (residues 144 to 148) leads to changes in the C-terminal region, particularly in the delKSF structure. New investigations must be carried out to analyze how these changes affect NSP1 activity during the infection. Our results reinforce the need for continuous genomic surveillance of SARS-CoV-2 to better understand virus evolution and assess the potential impact of the viral mutations on the approved vaccines and future therapies.

1 January 2024 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
PDF file
FZFernando Berton Zanchi
Fernando Berton Zanchi
GFGabriel Eduardo M. Ferreira
Gabriel Eduardo M. Ferreira
LMLuis André Mariuba
Luis André Mariuba
JGJuliane Glória
Juliane Glória
VNValdinete A. Do Nascimento
Valdinete A. Do Nascimento
Felipe NavecaFelipe Naveca
Felipe Naveca
The disease coronavirus COVID-19 has been the cause of millions of deaths worldwide. Among the proteins of SARS-CoV-2, non-structural protein 12 (NSP12) plays a key role during COVID infection and is part of the RNA-dependent RNA polymerase complex. The monitoring of NSP12 polymorphisms is extremely important for the design of new antiviral drugs and monitoring of viral evolution. This study analyzed the NSP12 mutations detected in circulating SARS-CoV-2 during the years 2020 to 2022 in the population of the city of Manaus, Amazonas, Brazil. The most frequent mutations found were P323L and G671S. Reports in the literature indicate that these mutations are related to transmissibility efficiency, which may have contributed to the extremely high numbers of cases in this location. In addition, two mutations described here (E796D and R914K) are close and have RMSD that is similar to the mutations M794V and N911K, which have been described in the literature as influential on the performance of the NSP12 enzyme. These data demonstrate the need to monitor the emergence of new mutations in NSP12 in order to better understand their consequences for the treatments currently used and in the design of new drugs.

18 March 2025 in Animals
Verified
Journal Article
Open access
PDF file
MCMaria Vitória Lobo Corado
Maria Vitória Lobo Corado
EPElcimara Cardoso Pereira
Elcimara Cardoso Pereira
TBTaísa Freitas Botinelly
Taísa Freitas Botinelly
JGJuliane Glória
Juliane Glória
RSRafael Luckwu de Sousa
Rafael Luckwu de Sousa
GTGuilherme Campos Tavares
Guilherme Campos Tavares
Infections with Flavobacterium oreochromis pose risks to the production of Colossoma macropomum. Since no therapeutic treatment exists for this disease in this aquatic host, prophylaxis through vaccination is one method for disease control. The enzyme-linked immunosorbent assay (ELISA) is widely used in aquaculture to assess animal immunity and, mainly, to validate vaccination protocols. The method based on the use of immunoglobulin Y (IgY) is an alternative to mammalian antibodies that should be considered due to its advantages over antibodies produced by small mammals. This study aimed to standardize an indirect ELISA (iELISA) protocol to validate the immunization of C. macropomum against F. oreochromis. For this, a hen and fish were immunized to obtain anti-C. macropomum and anti-F. oreochromis antibodies, respectively, which were used to standardize the test. Fish were inoculated with bacterin + adjuvant, bacterin alone, adjuvant alone, or phosphate-buffered saline, subjected to blood sampling, and monitored for up to 60 days. The iELISA was composed of the inactivated bacteria in the coating step, C. macropomum anti-Flavobacterium oreochromis as the primary antibody, and anti-C. macropomum IgY as the secondary antibody. The results demonstrate that the highest antibody titers were found in the organisms immunized with bacterin + adjuvant and bacterin. The iELISA enabled the detection of antibodies produced by C. macropomum, which were mediated by IgY specificity.

1 January 2026 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
VCValtemar F. Cardoso
Valtemar F. Cardoso
CSCaio C. DE Souza
Caio C. DE Souza
JGJuliane Glória
Juliane Glória
ESEliza Raquel D. DA Silva
Eliza Raquel D. DA Silva
AGAriamna María Dip Gandarilla
Ariamna María Dip Gandarilla
LMLuis André Mariuba
Luis André Mariuba
Molecular diagnosis is crucial for combating infectious diseases due to its high sensitivity and precision. However, its application in point-of-care testing (POCT) faces challenges, particularly in remote areas and developing countries. This review, based on searches of indexed publication databases, examined major nucleic acid amplification methods, detection techniques and miniaturization strategies for POCT platform development, focusing on the period 2015–2025. The need for regulatory standardization and the advantages and disadvantages of amplification techniques were discussed. Microfluidic approaches—reaction chambers, continuous flow, and droplets—were analyzed as the basis for functional device integration, emphasizing their role in reducing volumes, energy consumption and processing time. The sensitivity, cost and instrumentation complexity of fluorescence-, colorimetry- and electrochemistry-based detection systems were addressed. The practical feasibility of integrating these into miniaturized POCT platforms underscores the structural role of microfluidics in advancing portable molecular diagnostics. Despite progress, miniaturization complexity and reagent costs remain significant technological barriers.